Cited by 187Schizophrenia research and treatmentMental Health and PsychiatryMental Health and Patient Involvement

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Recovery from schizophrenia: is it possible?

Vita, Antonio, Barlati, Stefano·2018·Current Opinion in Psychiatry

Open this paper in CoChat — free account

Abstract

PURPOSE OF REVIEW: Schizophrenia has a heterogeneous range of end states, from severe cases requiring repeated hospitalization to cases in which a single illness episode is followed by complete remission. The purpose of the present review is to examine recent literature on recovery in schizophrenia, focusing on the predictive factors and on the possibility to achieve it. RECENT FINDINGS: Roughly half of schizophrenia patients recovered or significantly improved over the long term, suggesting that functional remission is possible. Several factors predict the course of schizophrenia, including demographic, clinical, and treatment characteristics, as well as socioeconomic variables. Antipsychotics are a fundamental element of schizophrenia treatment, although the available antipsychotics have significant limitations. In this context, psychosocial interventions are supported by substantial evidence of efficacy in many outcome measures and rehabilitation interventions should be considered as an evidence-based practice and need to become a part of the standard treatment of schizophrenia. SUMMARY: As recovery is a multidimensional concept, some authors suggested that at least two areas should be taken into account: clinical remission and social functioning. Functional outcome should be a priority target for therapeutic interventions in schizophrenia and in this perspective measuring treatment response, remission and functional recovery is essential. Only an integrated and multifaceted approach involving pharmacotherapy, psychosocial interventions, and attention to environmental circumstances can improve outcome in schizophrenia.

Integrity signals

Registry

Crossref · 10.1097/yco.0000000000000407

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Recovery from mental illness: the guiding vision of the mental health service system in the 1990s
Anthony, W. A. (1993) · Psychosocial Rehabilitation Journal · doi:10.1037/h0095655 · Cited by 3,700
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,350
Recovery from psychotic illness: A 15- and 25-year international follow-up study
Harrison, G., Hopper, K. J., Craig, T., LASKA, E. M., Siegel, C., WANDERLING, J. A., Dubé, K. C., Ganev, K., Giel, R., der Heiden, W. A., et al. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.6.506 · Cited by 1,059
Uses and abuses of recovery: implementing recovery-oriented practices in mental health systems
Slade, M., Amering, M., Farkas, M., Hamilton, B., O'Hagan, M., Panther, G., Perkins, R., Shepherd, G., Tse, S., & Whitley, R. (2014) · World Psychiatry · doi:10.1002/wps.20084 · Cited by 949
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Jääskeläinen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M. K., Veijola, J. M., & Miettunen, J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 909
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
Kane, J. M., Robinson, D. G., Schooler, N. R., Mueser, K. T., Penn, D. L., Rosenheck, R. A., Addington, J., Brunette, M. F., Correll, C. U., Estroff, S. E., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050632 · Cited by 896
The experience of recovery from schizophrenia: Towards an empirically validated stage model
Andresen, R., Oades, L., & Caputi, P. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01234.x · Cited by 871
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
Green, M. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.1006e12 · Cited by 794
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional Capacity, and Symptoms
Bowie, C. R., Reichenberg, A., Patterson, T. L., Heaton, R. K., & Harvey, P. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.418 · Cited by 764

Show all 87 references

Sorted by citations

Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia
Vita, A., Barlati, S., Ceraso, A., Nibbio, G., Ariu, C., Deste, G., & Wykes, T. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0620 · Cited by 503
Self-citation
Maintenance treatment with antipsychotic drugs for schizophrenia
Ceraso, A., Lin, J., Schneider‐Thoma, J., Siafis, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Davis, J. M., & Leucht, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub3 · Cited by 184
Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis.
Jansen, J. E., Gleeson, J., Bendall, S., Rice, S., & Alvarez-Jimenez, M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.016 · Cited by 144
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
Vita, A., Gäebel, W., Mucci, A., Sachs, G., Barlati, S., Giordano, G. M., Nibbio, G., Nordentoft, M., Wykes, T., & Galderisi, S. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.2315 · Cited by 154
Self-citation
The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: A clinical review
Fiorillo, A., Barlati, S., Bellomo, A., Corrivetti, G., Nicolò, G., Sampogna, G., Stanga, V., Veltro, F., Maina, G., & Vita, A. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00293-4 · Cited by 110
Self-citation
The efficacy of meditation-based mind-body interventions for mental disorders: A meta-review of 17 meta-analyses of randomized controlled trials
Vancampfort, D., Stubbs, B., Van Damme, T., Smith, L., Hallgren, M., Schuch, F., Deenik, J., Rosenbaum, S., Ashdown-Franks, G., Mugisha, J., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.048 · Cited by 99
Schizophrenia outcomes in the 21st century: A systematic review
Huxley, P. J., Krayer, A., Poole, R., Prendergast, L. M., Aryal, S., & Warner, R. (2021) · Brain and Behavior · doi:10.1002/brb3.2172 · Cited by 83
Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis
Catalán, A., Richter, A., de Pablo, G. S., Vaquerizo‐Serrano, J., Mancebo, G., Pedruzo, B., Aymerich, C., Solmi, M., Torres, M. Á. G., Gil, P., et al. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.2246 · Cited by 79
Evidence-based psychosocial interventions in schizophrenia: a critical review
Barlati, S., Nibbio, G., & Vita, A. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000925 · Cited by 102
Self-citation
Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
Laszlovszky, I., Barabássy, Á., & Németh, G. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01797-5 · Cited by 78
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services
Vita, A., & Barlati, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00147 · Cited by 79
Self-citation
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Vita, A., Barlati, S., Ceraso, A., Nibbio, G., Durante, F., Facchi, M., Deste, G., & Wykes, T. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230396 · Cited by 85
Self-citation
A palliative care approach in psychiatry: clinical implications
Strand, M., Sjöstrand, M., & Lindblad, A. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00472-8 · Cited by 71
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
Pietrini, F., Albert, U., Ballerini, A., Calò, P., Maina, G., Pinna, F., Vaggi, M., Boggian, I., Fontana, M., Moro, C. G., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199048 · Cited by 61
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Vita, A., Minelli, A., Barlati, S., Deste, G., Giacopuzzi, E., Valsecchi, P., Turrina, C., & Gennarelli, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00402 · Cited by 57
Self-citation
The impact of internalized stigma on the well-being of people with Schizophrenia
Morgades-Bamba, C. I., Fuster‐RuizdeApodaca, M. J., & Molero, F. J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.060 · Cited by 59
Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial
Maurus, I., Roell, L., Lembeck, M., Papazova, I., Greska, D., Muenz, S., Wagner, E. M., Campana, M., Schwaiger, R., Schneider-Axmann, T., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115480 · Cited by 57
Trends in big data analyses by multicenter collaborative translational research in psychiatry
Onitsuka, T., Hirano, Y., Nemoto, K., Hashimoto, N., Kushima, I., Koshiyama, D., Koeda, M., Takahashi, T., Noda, Y., Matsumoto, J., et al. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13311 · Cited by 53
Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak—An Exploratory Cross-Sectional Analysis of a Population-Based Register Study
Maripuu, M., Bendix, M., Öhlund, L., Widerström, M., & Werneke, U. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.609579 · Cited by 46
Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting
Nibbio, G., Barlati, S., Cacciani, P., Corsini, P., Mosca, A., Ceraso, A., Deste, G., & Vita, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103352 · Cited by 41
Self-citation
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review
Deste, G., Corbo, D., Nibbio, G., Italia, M., Dell'Ovo, D., Calzavara‐Pinton, I., Lisoni, J., Barlati, S., Gasparotti, R., & Vita, A. (2023) · Brain Sciences · doi:10.3390/brainsci13020320 · Cited by 37
Self-citation
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Vita, A., Nibbio, G., & Barlati, S. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116126 · Cited by 36
Self-citation
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review
Barlati, S., Deste, G., Galluzzo, A., Perin, A. P., Valsecchi, P., Turrina, C., & Vita, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01542 · Cited by 34
Self-citation
Subjective Recovery in Patients with Schizophrenia and Related Factors
İpçi, K., Yıldız, M., İncedere, A., Kiras, F., Esen, D., & Gürcan, M. B. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00616-5 · Cited by 39
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Vita, A., Nibbio, G., & Barlati, S. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae013 · Cited by 34
Self-citation
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses
Giuliani, L., Giordano, G. M., Bucci, P., Pezzella, P., Brando, F., & Galderisi, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791117 · Cited by 29
Defining recovery in schizophrenia: A review of outcome studies
Ponce-Correa, F., Caqueo‐Urízar, A., Berríos, R., & Escobar-Soler, C. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115134 · Cited by 31
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community
Vita, A., Barlati, S., Deste, G., Nibbio, G., Penn, D. L., Pinkham, A. E., McIntyre, R. S., & Harvey, P. D. (2023) · Psychological Medicine · doi:10.1017/s0033291723002106 · Cited by 29
Self-citation
Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial
Maurus, I., Hasan, A., Schmitt, A., Roeh, A., Keeser, D., Malchow, B., Schneider-Axmann, T., Hellmich, M., Schmied, S., Lembeck, M., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01175-2 · Cited by 26
Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration
Kim, S., Kim, S., Koh, M., Choi, G., Kim, J.-J., Paik, I., Kim, S., Choi, Y. S., Lee, Y. H., Suh, J., et al. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13446 · Cited by 27
The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders—Replicating a Network Analysis Study
Moura, B. M., Isvoranu, A., Kovács, V., van Rooijen, G., van Amelsvoort, T., Simons, C. J. P., Bartels‐Velthuis, A. A., Bakker, P. R., Marcelis, M. C., de Haan, L., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac018 · Cited by 26
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
Giordano, G. M., Brando, F., Pezzella, P., Angelis, M. D., Mucci, A., & Galderisi, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.970210 · Cited by 28
Inter-relationships among psychopathology, cognition, and real-life functioning in early and late phase schizophrenia: A network analysis approach
Brasso, C., Bellino, S., Bozzatello, P., Favero, E. D., Montemagni, C., & Rocca, P. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.04.011 · Cited by 25
The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China
Li, H., Huang, Y., Liang, L., Li, H., Li, S., Feng, Y., Feng, S., Wu, K., & Wu, F. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.03.053 · Cited by 25
Multiscale Weighted Permutation Entropy Analysis of Schizophrenia Magnetoencephalograms
Bai, D., Yao, W., Wang, S., & Wang, J. (2022) · Entropy · doi:10.3390/e24030314 · Cited by 24
Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients
Kališová, L., Michalec, J., Děchtěrenko, F., Petr, Š., Hýža, M., Chlebovcová, M., Brenova, M., & Bezdíček, O. (2023) · Schizophrenia · doi:10.1038/s41537-023-00374-9 · Cited by 26
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Calzavara‐Pinton, I., Nibbio, G., Barlati, S., Bertoni, L., Necchini, N., Zardini, D., Baglioni, A., Paolini, S., Poddighe, L., Bulgari, V., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14080791 · Cited by 23
Self-citation
Dissociative Model in Patients With Resistant Schizophrenia
Panov, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.845493 · Cited by 24
Association of Reduced Local Activities in the Default Mode and Sensorimotor Networks with Clinical Characteristics in First-diagnosed Episode of Schizophrenia
Gao, S., Ming, Y., Ni, S., Kong, Z., Wang, J., Gu, Y., Lu, S., Chen, T., Kong, M., Sun, J., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.020 · Cited by 20
A day in the life of people with severe mental illness living in supported housing
Tjörnstrand, C., Eklund, M., Bejerholm, U., Argentzell, E., & Brunt, D. A. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02896-3 · Cited by 21
Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin’s and Bleuler’s conceptions
Maes, M. H. J. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.32 · Cited by 19
Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
García‐Portilla, M. P., García-Álvarez, L., González-Blanco, L., Santo, F. D., Bobes-Bascarán, T., Martínez-Cao, C., García-Fernández, A., Sáiz, P. A., & Bobes, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.700747 · Cited by 18
Mediating effect of empowerment on the relationship between global function and personal recovery among community-dwelling patients with schizophrenia: a cross-sectional study
Lee, K. T., Lee, S. K., Lu, M. J., Hsieh, W. L., & Liu, W. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03239-6 · Cited by 17
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Vita, A., Barlati, S., Cavallaro, R., Mucci, A., Riva, M. A., Rocca, P., Rossi, A., & Galderisi, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1451832 · Cited by 28
Self-citation
Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment
Panov, G., Dyulgerova, S., & Panova, P. (2023) · Biomedicines · doi:10.3390/biomedicines11123114 · Cited by 20
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning
Giordano, G. M., Giuliani, L., Perrottelli, A., Bucci, P., Lorenzo, G. D., Siracusano, A., Brando, F., Pezzella, P., Fabrazzo, M., Altamura, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245838 · Cited by 15
Community-based recovery interventions for improving mental health in schizophrenia patients: a scoping review in Southeast Asia
Hikmat, R., Suryani, S., Yosep, I., Jeharsae, R., Widianti, E., Hidayati, N. O., Sutini, T., Hernawaty, T., Sriati, A., & Rafiyah, I. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06962-6 · Cited by 14
Engineered PLGA microspheres for extended release of brexpiprazole: in vitro and in vivo studies
Wu, B., Wu, L., He, Y., Yin, Z., & Deng, L. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1934859 · Cited by 14
Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT)
Halverson, T. F., Meyer-Kalos, P., Perkins, D. O., Gaylord, S. A., Palsson, O. S., Nye, L., Algoe, S. B., Grewen, K., & Penn, D. L. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.07.022 · Cited by 16
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
Guo, H., Ye, H., Li, Z., Li, X., Huang, W., Yang, Y., Xie, G., Xu, C., Li, X., Liang, W., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04728-6 · Cited by 16
Major Neuropsychological Impairments in Schizophrenia Patients: Clinical Implications
Jones, M. T., & Harvey, P. D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01181-0 · Cited by 15
Patterns of Care for Adolescent With Schizophrenia: A Delphi-Based Consensus Study
Vita, A., Barlati, S., Bellomo, A., Fusar‐Poli, P., Masi, G., Nobili, L., Serafini, G., Zuddas, A., & Vicari, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.844098 · Cited by 13
Self-citation
A New Treatment Paradigm
Kane, J. M. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001596 · Cited by 15
Mechanisms of action and processes of yoga-based group intervention for inpatients with schizophrenia spectrum disorders–A longitudinal qualitative study
Töbelmann, L., Hahne, I., Schulze, T., Bergmann, N., Fuchs, L., Zierhut, M., Hahn, E., & Böge, K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1086468 · Cited by 13
The Effect of Mindfulness-Based Psychosocial Skills Training on Functioning and Insight Level in Patients with Schizophrenia
Yüksel, A., & Yılmaz, E. B. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00658-9 · Cited by 21
Candidates for Drug Repurposing to Address the Cognitive Symptoms in Schizophrenia
Koch, E. M., Kauppi, K., & Chen, C. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110637 · Cited by 14
Achieving long-term goals through early personalized management of schizophrenia: expert opinion on the role of a new fast-onset long-acting injectable antipsychotic
Vita, A., Fagiolini, A. M., Maina, G., Mencacci, C., Spina, E., & Galderisi, S. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-022-00430-1 · Cited by 12
Self-citation
Interactome overlap between schizophrenia and cognition
Koch, E. M., Rosenthal, S. B., Lundquist, A., Chen, C., & Kauppi, K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.002 · Cited by 12
Integrating the social determinants of mental health into case conceptualization and treatment planning
Lenz, A. S., & Litam, S. D. A. (2023) · Journal of Counseling & Development · doi:10.1002/jcad.12487 · Cited by 15
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
Brasso, C., Bellino, S., Bozzatello, P., Montemagni, C., Nobili, M. G. A., Sgro, R., & Rocca, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12226985 · Cited by 15
The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study
Calzavara‐Pinton, I., Nibbio, G., Bertoni, L., Cicale, A., Necchini, N., Zardini, D., Ubertino, U. B., Cerati, C., Deste, G., Barlati, S., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116240 · Cited by 17
Self-citation
Recovery and Recovering in Older Adults with Schizophrenia: A 5-Tier Model
Cohen, C. I., & Reinhardt, M. M. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.03.008 · Cited by 11
Prevalence, risk factors and multiple outcomes of treatment delay in Chinese patients with schizophrenia
Yu, Y.-H., & Lu, Q. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05247-0 · Cited by 10
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review
Lisoni, J., Nibbio, G., Baglioni, A., Dini, S., Manera, B., Maccari, A., Altieri, L., Calzavara‐Pinton, I., Zucchetti, A., Deste, G., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14111067 · Cited by 11
Self-citation
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
Barlati, S., Nibbio, G., Bianchi, F. P., Gigli, E. B. L., Calzavara‐Pinton, I., Cerati, C., Fiori, J., Lisoni, J., Deste, G., & Vita, A. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114878 · Cited by 10
Self-citation
Conceptualisation and Definition of Personal Recovery among People with Schizophrenia: Additionally Review
Thongsalab, J., Yunibhand, J., & Uthis, P. (2023) · The Open Nursing Journal · doi:10.2174/18744346-v17-e230403-2023-17 · Cited by 11
Treatment Goals for Patients with Schizophrenia — A Narrative Review of Physician and Patient Perspectives
Gründer, G., Bauknecht, P., Klingberg, S., Leopold, K., Paulzen, M., Schell, S., Stengler, K., & Leucht, S. (2020) · Pharmacopsychiatry · doi:10.1055/a-1298-4546 · Cited by 10
Self- and caregiver-perceived disability, subjective well-being, quality of life and psychopathology improvement in long-acting antipsychotic treatments: a 2-year follow-up study
Pietrini, F., Tatini, L., Santarelli, G., Brugnolo, D., Squillace, M., Bozza, B., Ballerini, A., Ricca, V., & D’Anna, G. (2021) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2021.1912358 · Cited by 10
From Wish to Reality: Soteria in Regular Care—Proof of Effectiveness of the Implementation of Soteria Elements in Acute Psychiatry
Wolf, T., Fabel, P., Kraschewski, A., & Jockers-Scherübl, M. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.685779 · Cited by 10
Evaluating the Acceptance of Cinematic Virtual Reality-Based Applications for Rehabilitative Interventions in Schizophrenia
Manghisi, V. M., Evangelista, A., Semisa, D., Latorre, V., & Uva, A. E. (2022) · Games for Health Journal · doi:10.1089/g4h.2021.0223 · Cited by 10
Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study
D’Anna, G., Zarbo, C., Cardamone, G., Zamparini, M., Calza, S., Rota, M., Correll, C. U., Rocchetti, M., Starace, F., de Girolamo, G., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00372-x · Cited by 11
Self-citation
Metacognition as a Transdiagnostic Determinant of Recovery in Schizotypy and Schizophrenia Spectrum Disorders
Wiesepape, C. N., Smith, E. A., Hillis, J. D., Soza, S. E. Q., Morris, M., James, A. V., & Stokes, A. B. (2024) · Behavioral Sciences · doi:10.3390/bs14040336 · Cited by 11
Antipsychotic clozapine binding to alpha-2-macroglobulin protects interacting partners against oxidation and preserves the anti-proteinase activity of the protein
Šunderić, M., Vasović, T. D., Milčić, M. K., Miljević, Č., Nedić, O., Nikolic, M. R., & Gligorijević, N. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.155 · Cited by 10
Childhood trauma exposure and personality traits in schizophrenia patients
Adanty, C., Qian, J., Wang, Y., Remington, G. J., Shakeri, A., Borlido, C., Gerretsen, P., Graff‐Guerrero, A., & Luca, V. D. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.01.039 · Cited by 9
Neurocognition and functioning in adolescents at clinical high risk for psychosis
Mensi, M. M., Marika, O., Casini, E., Catalán, A., de Pablo, G. S., Fusar‐Poli, P., & Borgatti, R. (2023) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-023-00567-1 · Cited by 9
Assessment of interrelationships between cognitive performance, symptomatic manifestation and social functioning in the acute and clinical stability phase of schizophrenia: insights from a network analysis
Misiak, B., Piotrowski, P., & Samochowiec, J. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05289-4 · Cited by 9
Quercetin exerts neuroprotective effects through activation of PI3K/AKT/CREB/BDNF signaling pathway in double blow model-induced schizophrenia-like mice
Yang, Y., Li, M., Liu, Y., Luo, B., Ge, M., Zhang, K., liu, H., & He, H. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178272 · Cited by 8
Real-World Functioning in Psychiatric Outpatients: Predictive Factors
Bozzatello, P., Giordano, B., Montemagni, C., Rocca, P., & Bellino, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154400 · Cited by 9
The Recovery Process for Individuals With Schizophrenia in the Context of Evidence-Based Psychotherapy and Rehabilitation
Rakitzi, S., Georgila, P., & Becker-Woitag, A. P. (2020) · European Psychologist · doi:10.1027/1016-9040/a000400 · Cited by 8
Determinants of Clinical Recovery in Schizophrenia
Giordano, G. M., Galderisi, S., Pezzella, P., Perrottelli, A., & Bucci, P. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_2 · Cited by 8
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study
Chiappini, S., Carlo, F. D., Mosca, A., d’Andrea, G., Paolo, M. D., Lorenzini, C., Lupica, M. G., Sampogna, G., Pettorruso, M., Fiorillo, A., et al. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s418627 · Cited by 8
Model of complex rehabilitation for patients with a simple form of schizophrenia
Chuhunov, V. V., Курило, В. О., Pidlubnyi, V. L., & Kanyhina, S. M. (2021) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2021.1.224910 · Cited by 7
Deficits in Key Brain Network for Social Interaction in Individuals with Schizophrenia
Wu, Y., Wang, H., Li, C., Zhang, C., Li, Q., Shao, Y., Yang, Z., Li, C., & Fan, Q. (2023) · Brain Sciences · doi:10.3390/brainsci13101403 · Cited by 8
An Integrated Account of Expert Perspectives on Functioning in Schizophrenia
Nuño, L., Guilera, G., Rojo, E., Gómez‐Benito, J., & Barrios, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184223 · Cited by 7
Psychiatric rehabilitation patterns in Italy: Results from the Italian Society of Psychosocial Rehabilitation (SIRP) survey
Viganò, C. A., Ariu, C., Barbieri, D., Goffredi, A., Ferrara, L., Rea, F., Barlati, S., Vita, A., & SIRP Survey Group (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130811 · Cited by 7
Self-citation
Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
Lang, X., Xue, M., Zang, X., Wu, F., Xiu, M., & Zhang, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04272-7 · Cited by 7
Analysis of color vision and cognitive function in first-episode schizophrenia before and after antipsychotic treatment
Duan, L., Tian, C., Fu, C., He, J., Dai, J., Shao, X., & Zhu, G. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.012 · Cited by 6
The Effects of an Equine-Assisted Therapeutic Intervention on Well-Being in Persons Diagnosed with Schizophrenia. A Pilot Study
Cappelen, H., Ivarsson, A., & Jormfeldt, H. (2023) · Issues in Mental Health Nursing · doi:10.1080/01612840.2022.2158408 · Cited by 6
Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
Skouras, S., Kleinert, M.-L., Lee, E. H. M., Hui, C. L. M., Suen, Y. N., Camchong, J., Chong, C. S. Y., Chang, W. C., Chan, S. K. W., Lo, W. T.-L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae094 · Cited by 6
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia
Boskovic, D. H., Smith‐Palmer, J., Pöhlmann, J., Pollock, R. F., Hwang, S., & Bruhn, D. (2024) · Patient Related Outcome Measures · doi:10.2147/prom.s454845 · Cited by 6
Well-Being and Mental Health
Nibbio, G., Calzavara‐Pinton, I., Barlati, S., Necchini, N., Bertoni, L., Lisoni, J., Stanga, V., Deste, G., Turrina, C., & Vita, A. (2024) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001815 · Cited by 7
Self-citation
Social Intervention as an Adjuvant Therapy for Patients with Schizophrenia
Dobrin, I., Chiriță, R., Dobrin, R., Bîrsan, M., Ștefănescu, C., Truş, C., & Cristofor, A. C. (2020) · Revista de Cercetare si Interventie Sociala · doi:10.33788/rcis.68.18 · Cited by 6
Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
Shi, H., Xu, J., Lang, X., Wu, H. E., Xiu, M. H., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.863588 · Cited by 6
Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial
Zhu, C., Guan, X., Wang, Y., Liu, J., Kosten, T. R., Xiu, M., Wu, F., & Zhang, X. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01242-7 · Cited by 6
Family perspectives on severe mental disorders and relapse prevention: a qualitative study
Sawab, S., Yusuf, A., Rizki Fitryasari, P. K., Pujiastuti, R. R. S. E., & Putra, P. (2023) · Journal of Public Health in Africa · doi:10.4081/jphia.2023.2572 · Cited by 6
Evolution of Linguistic Markers of Agency, Centrality and Content During Metacognitive Therapy for Psychosis: A Pilot Exploratory Study
Nikzad, A. H., Lysaker, P. H., Minor, K. S., Leonhardt, B. L., Liberman, M., Vohs, J. L., Wiesepape, C. N., & Tang, S. X. (2024) · Early Intervention in Psychiatry · doi:10.1111/eip.13628 · Cited by 6
Analyse qualitative du vécu d’aidants familiaux de patients atteints de schizophrénie à différents stades d’évolution de la maladie
Goleto, S. D., Younès, N., Grevin, I., Kostova, M., & Blanchet, A. (2019) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2018.10.015 · Cited by 5
The Patient Journey of Schizophrenia in Mental Health Services: Results from a Co-Designed Survey by Clinicians, Expert Patients and Caregivers
Percudani, M., Iardino, R., Porcellana, M., Lisoni, J., Brogonzoli, L., Barlati, S., & Vita, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050822 · Cited by 5
Self-citation
Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial
Xiu, M., Zhao, L., Sun, Q., & Lang, X. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230913152344 · Cited by 5
Effectiveness of a needs-tailored nurse-led recovery program for community-dwelling people with schizophrenia: a cluster-randomized controlled trial
Liu, W., Hsieh, W., Lai, J. C.-T., Liu, C.-C., Tai, Y., & Liu, C. (2024) · BMC Nursing · doi:10.1186/s12912-024-01986-x · Cited by 9

Authors: Vita, A., & Barlati, S.
Affiliations: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
Corresponding author: Vita, Antonio
ORCID: Vita, Antonio
Venue: Current Opinion in Psychiatry
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2018-05
Volume: 31
Issue: 3
Pages: 246-255
ISSN: 0951-7367 (ISSN-L)
DOI: 10.1097/yco.0000000000000407
OpenAlex: W2789223245
Cited by: 187
References: 87
Citations by year: 2026: 9 · 2025: 17 · 2024: 37 · 2023: 37 · 2022: 32 · 2021: 24 · 2020: 22 · 2019: 7 · 2018: 2
FWCI: 2.09
Type: journal article
Language: en
Open access: closed
Locations: Current Opinion in Psychiatry (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
Keywords: schizophrenia, recovery, functional remission, social functioning, clinical remission, predictive factors, antipsychotic drugs, psychosocial interventions, rehabilitation, treatment response, socioeconomic factors
MeSH terms: Psychiatric Rehabilitation, Humans, Prognosis, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Recovery of Function, Evidence-Based Practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recovery from schizophrenia: is it possible?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks